Eupalinolide A(b)

CAS No. 877822-40-7

Eupalinolide A(b)( —— )

Catalog No. M20698 CAS No. 877822-40-7

Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 79 In Stock
5MG 63 In Stock
10MG 100 In Stock
25MG 211 In Stock
50MG 305 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Eupalinolide A(b)
  • Note
    Research use only, not for human use.
  • Brief Description
    Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.
  • Description
    Eupalinolide B is a natural product and demonstrates potent cytotoxicity against A-549 BGC-823 SMMC-7721 and HL-60 tumour cell lines.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    HSP
  • Recptor
    HSP90
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    877822-40-7
  • Formula Weight
    462.49
  • Molecular Formula
    C24H30O9
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (216.22 mM)
  • SMILES
    CC(=O)OC\C1=C/C[C@H](OC(C)=O)\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]2[C@@H](C1)OC(=O)C(\C)=C\CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yamashita Y Ikeda T Matsuda M et al. Purification and characterization of HSP-inducers from Eupatorium lindleyanum[J]. Biochemical Pharmacology 2012 83(7):909-922.
molnova catalog
related products
  • PU-H71

    PU-H71 is a potent and selective inhibitor of HSP90 with IC50 of 51 nM. Phase 1.

  • A-17

    A potent Hsp90α/p23 interaction inhibitor with IC50 of 0.15 uM.

  • A-674563 HCl

    A-674563 is an orally available, ATP-competitive, and reversible inhibitor of Akt (Ki: 11 nM for Akt1) .